Trial Profile
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 May 2019
Price :
$35
*
At a glance
- Drugs Levomequitazine (Primary) ; Desloratadine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 30 May 2019 This trial has been completed in Poland, according to European Clinical Trials Database.
- 30 May 2019 This trial has been completed in Poland, according to European Clinical Trials Database.
- 24 Nov 2018 This trial has been completed in Spain, according to European Clinical Trials Database.